Applications of nanoparticles in treatment and diagnosis of leukemia

Materials Science and Engineering C

Volumn 47, Issue , 2015, Pages 156-164

  Soni, Govind ^a   Yadav, Khushwant S ^a  

^a Rajeev Gandhi College of Pharmacy   (India)

Author keywords

Cell lines; Diagnosis; Leukemia; Nanoparticles; Reversal of multidrug resistance; Treatment

Indexed keywords

CELL CULTURE; CHEMOTHERAPY; CONTROLLED DRUG DELIVERY; DIAGNOSIS; DISEASES; DRUG INTERACTIONS; TARGETED DRUG DELIVERY;

ANTICANCER DRUG; BIOLOGICAL TARGETS; CELL LINES; INTRACELLULAR DELIVERY; LEUKEMIA; MOLECULAR LEVELS; MULTIDRUG RESISTANCE; TREATMENT;

NANOPARTICLES;

ANTINEOPLASTIC AGENT; NANOPARTICLE;

ANIMAL; LEUKEMIA;

ANIMALS; ANTINEOPLASTIC AGENTS; LEUKEMIA; NANOPARTICLES;

EID: 84911925437     PISSN: 09284931     EISSN: 18730191     Source Type: Journal    
DOI: 10.1016/j.msec.2014.10.043     Document Type: Review

References (72)

1. E. Kawasaki, and A. Player Nanotechnology, nanomedicine, and the development of new, effective therapies for cancer Nanomedicine 1 2005 101 109
2. G. Soni, and K.S. Yadav Nanogels as potential nanomedicine carrier for treatment of cancer: a mini review of the state of the art Saudi Pharm. J. 2014 10.1016/j.jsps.2014.04.001
3. H. Maeda The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor selective macromolecular drug targeting Adv. Enzyme Regul. 41 2001 189 207
4. A. Wang, F. Gu, L. Zhang, J. Chan, A. Radovic-Moreno, M. Shaikh, and O. Farokhzad Biofunctionalized targeted nanoparticles for therapeutic applications Expert. Opin. Biol. Ther. 8 8 2008 1063 1070
5. G. Barratt Colloidal drug carriers: achievements and perspectives Cell. Mol. Life Sci. 60 2003 21 37
6. R. Müller, and C. Keck Challenges and solutions for the delivery of biotech drugs - a review of drug nanocrystal technology and lipid nanoparticles J. Biotechnol. 113 2004 151 170
7. S. Wissing, O. Kayser, and R. Muller Solid lipid nanoparticles for parenteral drug delivery Adv. Drug Deliv. Rev. 56 2004 1257 1272
8. J. Koziara, P. Lockman, D. Allen, and R. Mumper Paclitaxel nanoparticles for the potential treatment of brain tumors J. Control. Release 99 2004 259 269
9. J. Panyam, and V. Labhasetwar Sustained cytoplasmic delivery of drugs with intracellular receptors using biodegradable nanoparticles Mol. Pharm. 1 2004 77 84
10. J. Anderson, and M. Shive Biodegradation and biocompatibility of PLA and PLGA microspheres Adv. Drug Deliv. Rev. 28 1997 5 24
11. J. Chae, S. Mo, and I. Oh Effects of poloxamer 188 on the characteristics of poly(lactide-co-glycolide) nanoparticles J. Nanosci. Nanotechnol. 10 5 2010 3224 3327
12. M.D. Tiwari, S. Mehra, S. Jadhav, and J.R. Bellare All-trans retinoic acid loaded block copolymer nanoparticles efficiently induce cellular differentiation in HL-60 cells Eur. J. Pharm. Sci. 44 5 2011 643 652
13. K. Yadav, and K. Sawant Formulation optimization of etoposide loaded PLGA nanoparticles by double factorial design and their evaluation Curr. Drug Deliv. 7 2010 51 64
14. K. Yadav, and K. Sawant Modified nanoprecipitation method for preparation of cytarabine loaded PLGA nanoparticles AAPS PharmSciTech 11 2010 1456 1465
15. J. Wang, B. Chen, J. Chen, X. Cai, G. Xia, R. Liu, P. Chen, Y. Zhang, and X. Wang Synthesis and antitumor efficacy of daunorubicin-loaded magnetic nanoparticles Int. J. Nanomedicine 6 2011 203 211
16. M. Simeonova, G. Ivanova, V. Enchev, N. Markova, M. Kamburov, C. Petkov, A. Devery, R. O'Connor, and D. Brougham Physicochemical characterization and in vitro behavior of daunorubicin-loaded poly(butylcyanoacrylate) nanoparticles Acta Biomater. 5 2009 2109 2121
17. R. Gref, Y. Minamitake, M. Peracchia, V. Trubetskoy, V. Torchilin, and R. Langer Biodegradable long-circulating polymeric nanospheres Science 263 1994 1600 1603
18. K. Avgoustakis, A. Beletsi, and Z. Panagi Effect of copolymer composition on the physicochemical characteristics, in vitro stability, and biodistribution of PLGA-mPEG nanoparticles Int. J. Pharm. 259 2003 115 127
19. K. Yadav, K. Chuttani, A. Mishra, and K. Sawant Long circulating nanoparticles of etoposide using PLGA-MPEG and PLGA-PLURONIC block copolymers: characterization, drug-release, blood-clearance, and biodistribution studies Drug Dev. Res. 71 2010 228 239
20. B. Lundberg Preparation and characterization of polymeric pH-sensitive STEALTH(®) nanoparticles for tumor delivery of a lipophilic prodrug of paclitaxel Int. J. Pharm. 408 1 2011 208 212
21. W. Zhiqing, L. Wei, X. Huibi, and Y. Xiangliang Preparation and in vitro studies of stealth PEGylated PLGA nanoparticles as carriers for arsenic trioxide Chin. J. Chem. Eng. 15 6 2007 795 801
22. Z. Yang, M. Yang, and J. Peng Evaluation of arsenic trioxide-loaded albumin nanoparticles as carriers: preparation and antitumor efficacy Drug Dev. Ind. Pharm. 34 8 2008 834 849
23. U. Termsarasab, I.S. Yoon, J.H. Park, H.T. Moon, H.J. Cho, and D.D. Kim Polyethylene glycol-modified arachidyl chitosan-based nanoparticles for prolonged blood circulation of doxorubicin Int. J. Pharm. 464 1 2014 127 134
24. X.Y. Gong, Y.H. Yin, Z.J. Huang, B. Lu, P.H. Xu, H. Zheng, and X.B. Gu Preparation, characterization and in vitro release study of a glutathione-dependent polymeric prodrug Cis-3-(9H-purin-6-ylthio)-acrylic acid-graft-carboxymethyl chitosan Int. J. Pharm. 436 1 2012 240 247
25. D. Dorniani, A.U. Kura, S.H. Hussein-Al-Ali, M.Z.B. Hussein, S. Fakurazi, A.H. Shaari, and Z. Ahmad Release behavior and toxicity profiles towards leukemia (WEHI-3B) cell lines of 6-mercaptopurine-PEG-coated magnetite nanoparticles delivery system Sci. World J. 2014 2014
26. J. Panyam, D. Williams, A. Dash, D. Leslie-Pelecky, and V. Labhasetwar Solid-state solubility influences encapsulation and release of hydrophobic drugs from PLGA/PLA nanoparticles J. Pharm. Sci. 93 7 2004 1804 1814
27. 4 nanoparticle copolymerizating daunorubicin and 5-bromotetrandrine in xenograft nude-mice Int. J. Nanomedicine 4 2009 73 78
28. G. Zhang, B. Lai, Y. Zhou, B. Chen, X. Wang, Q. Lu, and Y. Chen Fe(3)O(4) nanoparticles with daunorubicin induce apoptosis through caspase 8-PARP pathway and inhibit K562 leukemia cell-induced tumor growth in vivo Nanomedicine 2011 10.1016/j.nano.2011.01.013
29. C. Chen, G. Lv, C. Pan, M. Song, C. Wu, D. Guo, X. Wang, B. Chen, and Z. Gu Poly (lactic acid) (PLA) based nanocomposites - a novel way of drug-releasing Biomed. Mater. 2 4 2007 L1 L4
30. M.A. Moosavi, A.R. Khataee, and S. Moasses Ghafary Study of the photocatalytic effects of nitrogen-doped titanium dioxide nanoparticles on growth inhibition and apoptosis induction in K562 cell line Sci. J. Kurdistan Univ. Med. Sci. 18 1 2013 Pe47 Pe58
31. G. Joshi, A. Kumar, and K. Sawant Enhanced bioavailability and intestinal uptake of Gemcitabine HCl loaded PLGA nanoparticles after oral delivery Eur. J. Pharm. Sci. 60 2014 80 89
32. X. Jia, L. Tan, Y. Zhou, X. Jiang, Q. Xie, H. Tang, and S. Yao Magnetic immobilization and electrochemical detection of leukemia K562 cells Electrochem. Commun. 11 1 2009 141 144
33. Yu-Chuen Huang, Yuh-Cheng Yang, Kai-Chien Yang, Hui-Ru. Shieh, Tao-Yeuan Wang, Yeukuang Hwu, and Yu-Jen Chen Pegylated gold nanoparticles induce apoptosis in human chronic myeloid leukemia cells BioMed Res. Int. 2014 2014
34. D.D. Guo, C.H. Wu, X.M. Wang, and B.A. Chen Electrochemical study of the effect of functionalized nickel nanoparticles on cellular uptake of leukemia cancer cells in vitro Chin. Chem. Lett. 19 5 2008 577 580
35. M. Premanathan, K. Karthikeyan, K. Jeyasubramanian, and G. Manivannan Selective toxicity of ZnO nanoparticles toward Gram-positive bacteria and cancer cells by apoptosis through lipid peroxidation Nanomedicine 7 2011 184 192
36. P. Anand, H. Nair, B. Sung, A. Kunnumakkara, V. Yadav, Tekma l R., and B. Aggarwal Design of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivo Biochem. Pharmacol. 71 2010 330 338
37. J. Ravindran, H. Nair, B. Sung, S. Prasad, R. Tekmal, and B. Aggarwal Thymoquinone poly(lactide-co-glycolide) nanoparticles exhibit enhanced anti-proliferative, anti-inflammatory, and chemosensitization potential Biochem. Pharmacol. 79 2010 1640 1647
38. K. Yadav, S. Jacob, G. Sachdeva, and K. Sawant Intracellular delivery of etoposide loaded biodegradable nanoparticles: cytotoxicity and cellular uptake studies J. Nanosci. Nanotechnol. 11 2011 6657 6667
39. D. Guo, L. Zhu, and Z. Huang Anti-leukemia activity of PVP-coated silver nanoparticles via generation of reactive oxygen species and release of silver ions Biomaterials 34 32 2013 7884 7894
40. J. Smith, C. Medley, Z. Tang, D. Shangguan, C. Lofton, and W. Tan Aptamer-conjugated nanoparticles for the collection and detection of multiple cancer cells Anal. Chem. 79 2007 3075 3082
41. T. Deng, J. Li, L. Zhang, J. Jiang, J. Chen, G.L. Shen, and R. Yu A sensitive fluorescence anisotropy method for the direct detection of cancer cells in whole blood based on aptamer-conjugated near-infrared fluorescent nanoparticles Biosens. Bioelectron. 25 2010 1587 1591
42. J. Herr, J. Smith, C. Medley, D. Shangguan, and W. Tan Aptamer-conjugated nanoparticles for selective collection and detection of cancer cells Anal. Chem. 78 2006 2918 2924
43. H. Hu, H. Jiang, X. Wang, and B. Chen Detection and distinguishability of leukemia cancer cells based on Au nanoparticles modified electrodes Electrochem. Commun. 10 2008 1121 1124
44. K. Jangpatarapongsa, D. Polpanich, V. Yamkamon, Y. Dittharot, J. Peng-On, R. Thiramanas, S. Hongeng, S. Jootar, L. Charoenmak, and P. Tangboriboonrat DNA detection of chronic myelogenous leukemia by magnetic nanoparticles Analyst 136 2011 354 358
45. C. Nguyen, J. Nguyen, S. Rutledge, J. Zhang, C. Wang, and G. Walker Detection of chronic lymphocytic leukemia cell surface markers using surface enhanced Raman scattering gold nanoparticles Cancer Lett. 292 2010 91 97
46. A.A. Ensafi, M. Taei, H.R. Rahmani, and T. Khayamian Sensitive DNA impedance biosensor for detection of cancer, chronic lymphocytic leukemia, based on gold nanoparticles/gold modified electrode Electrochim. Acta 56 24 2011 8176 8183
47. W. Shan, Y. Pan, H. Fang, M. Guo, Z. Nie, Y. Huang, and S. Yao An aptamer-based quartz crystal microbalance biosensor for sensitive and selective detection of leukemia cells using silver-enhanced gold nanoparticle label Talanta 126 2014 130 135
48. J. Gunn, S. Park, O. Veiseh, O. Press, and M. Zhang A pretargeted nanoparticle system for tumor cell labeling Mol. BioSyst. 7 2011 742 748
49. A. Harris, and D. Hochhauser Mechanisms of multidrug resistance in cancer treatment Acta Oncol. 31 1992 205 213
50. M. van den Heuvel-Eibrink, P. Sonneveld, and R. Pieters The prognostic significance of membrane transport-associated multidrug resistance (MDR) proteins in leukemia Int. J. Clin. Pharmacol. Ther. 38 2000 94 110
51. K. Swerts, B. De Moerloose, C. Dhooge, G. Laureys, Y. Benoit, and J. Philippe Prognostic significance of multidrug resistance-related proteins in childhood acute lymphoblastic leukaemia Eur. J. Cancer 42 2006 295 309
52. I. Brigger, C. Dubernet, and P. Couvreur Nanoparticles in cancer therapy and diagnosis Adv. Drug Deliv. Rev. 54 2002 631 651
53. R. Krishna, and L. Mayer Multidrug resistance (MDR) in cancer-mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs Eur. J. Cancer Sci. 11 2000 265 283
54. C. Vauthier, C. Dubernet, C. Chauvierre, I. Brigger, and P. Couvreur Drug delivery to resistant tumors: the potential of poly(alkyl cyanoacrylate) nanoparticles J. Control. Release 93 2003 151 160
55. H. Wong, R. Bendayan, A. Rauth, H. Xue, K. Babakhanian, and X. Wu A mechanistic study of enhanced doxorubicin uptake and retention in multidrug resistant breast cancer cells using a polymer-lipid hybrid nanoparticle system J. Pharmacol. Exp. Ther. 317 2006 1372 1381
56. 4 nanoparticle copolymerizating daunorubicin and MDR1 shRNA expression vector in leukemia cells Int. J. Nanomedicine 9 2010 437 444
57. E. Lee, K. Na, and Y. Bae Doxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumor J. Control. Release 103 2005 405 418
58. S. Sahoo, and V. Labhasetwar Enhanced antiproliferative activity of transferrin-conjugated paclitaxel-loaded nanoparticles is mediated via sustained intracellular drug retention Mol. Pharm. 2 2005 373 383
59. F. Némati, C. Dubernet, A. Colin de Verdière, M. Poupon, L. Treupel-Acar, F. Puisieux, and P. Couvreur Some parameters influencing cytotoxicity of free doxorubicin and doxorubicin-loaded nanoparticles in sensitive and multidrug resistant leucemic murine cells: incubation time, number of nanoparticles per cell Int. J. Pharm. 102 1994 55 62
60. H.B. Man, H. Kim, H.J. Kim, E. Robinson, W.K. Liu, E.K.H. Chow, and D. Ho Synthesis of nanodiamond-daunorubicin conjugates to overcome multidrug chemoresistance in leukemia Nanomedicine 10 2 2014 359 369
61. T. Allen Ligand-targeted therapeutics in anticancer therapy Nat. Rev. Cancer 2 2002 750 763
62. A. Bicho, I. Peca, A. Roque, and M. Cardoso Anti-CD8 conjugated nanoparticles to target mammalian cells expressing CD8 Int. J. Pharm. 399 2010 80 86
63. N. Dinauer, S. Balthasar, C. Weber, J. Kreuter, K. Langer, and H. von Briesen Selective targeting of antibody-conjugated nanoparticles to leukemic cells and primary T-lymphocytes Biomaterials 26 2005 5898 5906
64. L. Wang, W. Zhang, B. Xiu, Y. Ding, P. Li, W. Ye, Q. Zhu, and A. Liang Nanocomposite-siRNA approach for down-regulation of VEGF and its receptor in myeloid leukemia cells Int. J. Biol. Macromol. 63 2014 49 55
65. V. Krishnan, X. Xu, S.P. Barwe, X. Yang, K. Czymmek, S.A. Waldman, R.W. Mason, X. Jia, and A.K. Rajasekaran Dexamethasone-loaded block copolymer nanoparticles induce leukemia cell death and enhance therapeutic efficacy: a novel application in pediatric nanomedicine Mol. Pharm. 10 6 2013 2199 2210
66. S. Acharya, and S.K. Sahoo Sustained targeting of BcrAbl + leukemia cells by synergistic action of dual drug loaded nanoparticles and its implication for leukemia therapy Biomaterials 32 24 2011 5643 5662
67. D. Guo, C. Wu, H. Jiang, Q. Li, X. Wang, and B. Chen Synergistic cytotoxic effect of different sized ZnO nanoparticles and daunorubicin against leukemia cancer cells under UV irradiation J. Photochem. Photobiol. B 93 2008 119 126
68. P. Zhou, S. Hatziieremia, M. Elliott, L. Scobie, C. Crossan, A. Michie, T. Holyoake, G. Halbert, and H. Jørgensen Uptake of synthetic Low Density Lipoprotein by leukemic stem cells - a potential stem cell targeted drug delivery strategy J. Control. Release 148 2010 380 387
69. http://nano.cancer.gov/learn/now/clinical-trials.asp
70. http://ucsdnews.ucsd.edu/newsrel/science/Nanotechnology.asp
71. http://www.calandopharma.com/
72. http://www.siteman.wustl.edu/nanotechnology.aspx